Impel Neuropharma (IMPL) PT Lowered to $40 at Cowen
Tweet Send to a Friend
Cowen analyst Ken Cacciatore lowered the price target on Impel Neuropharma (NASDAQ: IMPL) to $40.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
